000			03667nam a22004815i 4500
001			978-3-540-33101-8
003			DE-He213
005			20161121230644.0
007			cr nn 008mamaa
008			100301s2006 gw | s |||| 0|eng d
020			_a9783540331018 _9978-3-540-33101-8
024	7		_a10.1007/978-3-540-33101-8 _2doi
050		4	_aRL1-803
072		7	_aMJK _2bicssc
072		7	_aMED017000 _2bisacsh
082	0	4	_a616.5 _223
245	1	0	_aHidradenitis Suppurativa _h[electronic resource] / _cedited by Gregor B. E. Jemec, Jean Revuz, James J. Leyden.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2006.
300			_aXVIII, 204 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aHidradenitis Suppurativa Introduction -- Verneuil and Verneuil’s Disease: an Historical Overview -- Clinical Presentation -- Pathology of Hidradenitis Suppurativa -- Imaging -- Associated Diseases: Causality or Complications? -- Hidradenitis Suppurativa and Crohn’s Disease -- Epidemiology -- Nosology and Classification -- Genetics of Hidradenitis Suppurativa -- Bacteriology of Hidradenitis Suppurativa -- Endocrinology -- Immunity -- Quality of Life in Hidradenitis Suppurativa -- Antibiotic Therapy -- Antiandrogens -- Oral Retinoids for Hidradenitis Suppurativa -- Immunosuppressive Therapy in Hidradenitis Suppurativa -- Zinc and Other Experimental Medical Treatments -- Biologics For Hidradenitis Suppurativa (Verneuil’s Disease in the Era of Biologics) -- Topical Treatment -- Surgery -- Radiation Therapy -- Experimental Physical Therapies -- Treatment -- Hidradenitis Suppurativa — Patients’ Frequently Asked Questions -- An Uncommon Valor.
520			_aThis is the first and most comprehensive book perts to give their opinion and interpretation of dedicated to the understanding and treatment the disease, and left our own point of view to the of hidradenitis suppurativa. The most recent chapters summarizing pathogenesis and the- monograph on this disease was Dr Benedek’s py. At points you may therefore find discussions supplement to Acta Dermatovenerologica in of e. g. apocrine glands with which the editors 1957 (1)! The long interval has not been justified may disagree, but rather than suppress infor- by a benign nature or quiet disposition of the tion we have sought to stimulate and inspire an disease. This is a common and debilitating dis- an open dialogue. The book is intended for both ease that significantly reduces the quality of life concrete factual information, as well as inspi- for patients. In spite of this it has not achieved a tion for further studies of aetiology, pathog- deserved level notoriety and scientific interest, esis and therapy. but remains an obscure an ill-understood men- We would like to thank our colleagues for ace to the patients. generously sharing their insight and knowledge. There may be several reasons for this neglect.
650		0	_aMedicine.
650		0	_aDermatology.
650		0	_aGynecology.
650		0	_aProctology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aDermatology.
650	2	4	_aGynecology.
650	2	4	_aProctology.
700	1		_aJemec, Gregor B. E. _eeditor.
700	1		_aRevuz, Jean. _eeditor.
700	1		_aLeyden, James J. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783540331001
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-540-33101-8
912			_aZDB-2-SME
950			_aMedicine (Springer-11650)
999			_c501987 _d501987